Mifepristone
·
5 MIN READ

Next steps in mifepristone court fight: What doctors should know

Federal appeals court will hear arguments on order that would prevent access to a safe and effective reproductive health care option. Learn more.

Public Health
May 31, 2023 ·
1 MIN READ

Digitally Enabled Care for Women’s Health

This virtual session dives into the current state of women’s health and maternal health and how digitally enabled care is promoting and enhancing women’s well-being.

series
Events
AMA STEPS Forward® Innovation Academy Webinar Series
Patient speaking with a doctor in an office
·
4 MIN READ

Clearing the air on treatment for menopausal symptoms

Ob-gyn Madelyn Butler, MD, says there are more options to tailor treatment for patients experiencing bothersome symptoms of perimenopause. Learn more.

Population Care
·
5 MIN READ

Top news stories from AMA Morning Rounds®: Week of April 10, 2023

In the news: “Hacktivist” threat in health care, autism rates among girls, xylazine in fentanyl, mifepristone decision sets a dangerous precedent and more.

Publications & Newsletters
·
2 MIN READ

Restored restrictions on mifepristone is a step backwards

Appeals court order undermines evidence-based decisions by the FDA.

Press Releases
·
13 MIN READ

Menopause, perimenopause, hormone therapy and other treatments with Madelyn Butler, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the latest in menopausal research, training and hormone therapy.

series
Public Health
AMA Update
·
13 MIN READ

Menopause, perimenopause, hormone therapy and other treatments with Madelyn Butler, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the latest in menopausal research, training and hormone therapy.

series
Public Health
AMA Update Podcast
Statue of Lady Justice
·
5 MIN READ

Judge’s ruling on mifepristone has no basis in medical science

AMA joins amicus brief to halt a federal court decision on mifepristone that threatens patient care and undermines public health.

series
Leadership
Leadership Viewpoints
·
3 MIN READ

AMA: Texas mifepristone ruling flies in the face of science

Today’s court decision removing mifepristone from the marketplace flies in the face of science and threatens to upend access to a safe and effective drug.

Press Releases